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Abstract
Laboratories represent a crucial link in the surveillance chain. 
Since only a small proportion of cases of enteric infections 
are asked to submit a stool sample, one needs to assess the 
practices for testing for enteric pathogens and their notification 
practices.
Five local laboratories participated in this study.  This 
included a description of the laboratory practices; capacity for 
stool sample analysis; awareness of the notification system 
and the factors which could improve the system at laboratory 
level.
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Three of the surveyed laboratories received a total of 2198 
specimens during 2005, most of which were submitted without 
transport media.  Salmonella and Campylobacter were usually 
sought in stool sample analysis.  Tests for E. coli 0157 and Shiga 
toxin producing E. coli (STEC) were conducted in two of the 
laboratories.  One of the laboratories conducted the test for 
Cryptosporidium, Cyclospora and Microsporidia.  The test for 
rotavirus was conducted in two of the laboratories whilst one 
laboratory sent samples for testing for norovirus abroad when 
clinically or epidemiologically indicated.  
All of the laboratories notified communicable diseases by 
regular mail.  Feedback from the surveillance unit was welcomed 
by these laboratories, preferably through the website.  Variations 
in testing for E. coli/STEC and parasites in different laboratories 
were observed.  
Standardisation of testing procedures between laboratories 
is essential.  The main limitation in laboratory reporting in the 
current system is the timeliness of notification which can be 
reduced by electronic data transfer from the laboratories to the 
national surveillance system.  However, laboratory reporting 
does not replace the clinician’s responsibility to notify cases.
Introduction
The limitations of passive surveillance systems compromise 
the accuracy and the quality of data.1-4  Laboratories performing 
tests to isolate enteric pathogens from stool specimens are 
a crucial link in the surveillance chain.5,6  It is known that a 
considerable number of stool specimens are negative for an 
aetiologic agent7 and they are classified as unspecified in local 
statistics.8  There are various reasons why a stool specimen from 
a case with symptoms of Infectious Intestinal Disease (IID) 
results in a negative finding.  These include:
•	 Condition of specimen unsuitable for testing
•	 Double pathogen may lead to identification of only one 
pathogen
•	 Error in testing
•	 Long delay or inappropriate transport conditions 
leading to pathogens dying
•	 Number of pathogens below threshold level
•	 Symptoms of IID were due to a non-infectious cause
•	 Testing for pathogen responsible for illness not done
•	 Testing not done in laboratory
•	 Sensitivity of diagnostic method
•	 Characteristic of affected patient
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Even when a pathogen is eventually identified, not all 
cases are reported to the surveillance chain.  Hence they are 
excluded from national statistics, leading to under-estimates. 
The Disease Surveillance Unit (DSU) within the Public Health 
Department is responsible for the surveillance of infectious 
intestinal disease.  This unit receives notifications from 
general practitioners, hospital physicians and laboratories. 
The majority of notifications received include cases which 
required hospitalisation or referral for stool culture analysis. 
To be included in the present surveillance system, an individual 
must first present to the health care provider who should notify 
the case.  
Of those that present to the health care provider, only a 
small proportion of specimens are submitted for microbiological 
testing.  Hence, the surveillance system captures only a tiny 
fraction of the infectious intestinal disease that is actually 
occurring in the community. In Malta, there is no published 
information on the practices that laboratories utilise to test for 
enteric pathogens; their analytical capabilities or their awareness 
to notification procedures.  Therefore, a study was carried out to 
address these lacunae, and is described in this paper. 
Methodology 
Aims and objectives
The aim of the survey was to identify practices in laboratories 
that impact on the sensitivity of finding an aetiologic agent in 
submitted stool specimens.
It focused on: 
•	 examination of  some of the variables that influence 
whether a bacterial, viral or parasitic pathogen is 
identified in a stool specimen
•	 assessment of the laboratory capacity (availability, 
functionality, and level of sophistication)  
•	 assessment on the awareness of the notification system 
•	 the factors which may improve the notification system 
at this level
Definition	and	selection	of	participants
All laboratories (3 privately-owned and 2 managed by the 
government service) in the Maltese islands (Malta and Gozo) 
receiving stool specimens were invited to participate in the 
study. The list of licensed laboratories that have the permit to 
test human stool samples was obtained from the Department 
of Public Health which recommend the issuing of these 
licenses.9
Questionnaire design
The questionnaire design was based on the information 
required to meet the main aim and objectives of the study.  The 
questionnaire included validated questions which were used 
in international studies in the United States10 and Canada.11 
Questions included information on recording and transfer of 
data, type of laboratory, number of stool specimens received, 
types of pathogens tested for and variation in notification 
practices and awareness.  
Pilot study
A pilot study using one laboratory was carried out to test the 
survey instrument, methodology and to identify any operational 
problems.  Ambiguous questions were amended.
Field work
Laboratories were contacted by phone to introduce the 
study, confirm receipt of stool specimens and to identify contact 
persons. An appointment was made and the questionnaire was 
delivered by hand to the responsible person who in turn duly 
filled in the questionnaire.
Data entry and analysis
The data obtained from the questionnaires was fed into the 
Statistical Package for Social Sciences (SPSS) statistical analysis 
program, as soon as the forms were returned and the data was 
subsequently analysed.
Data	protection	and	confidentiality	
The University of Malta Research Ethics Committee 
approved the study.  Consent from respondents to conduct the 
interview was obtained by telephone before the questionnaire 
was delivered. Data storage had security measures to limit 
access to the data management team only.  Backups were stored 
securely.  No identifiable data was released in any way.
Results
Participation rate
In accordance with the Medical and Kindred Act12 all medical 
diagnostic laboratories require a license from the Superintendent 
of Public Health in order to operate in Malta. There were five 
licensed laboratories that perform analysis on stool specimens 
at the time of study.  All of these laboratories participated in 
the study. Of these laboratories, one public laboratory was 
situated in hospital; the other public health laboratory covered 
public health samples; two laboratories were situated in private 
hospitals and another one in a private clinic. 
Specimen  transport for bacterial testing 
A total of 2198 stool specimens were received during 2005 
by three laboratories who responded to this part of the study, 
with the majority being in the main state hospital laboratory. 
They were routinely (>80% of times) received as faeces in a 
container without transport media; rarely (<20% of time) as 
faeces on ice or as a rectal swab with or without transport media. 
Only one of the laboratories received faeces in transport media. 
One laboratory sent stools for testing for bacteria to another 
laboratory as isolates on slopes. One laboratory occasionally 
sent samples for further phage typing abroad since this facility 
is not available in Malta.   There were no changes in the off-site 
reference facilities in the previous two years for those who used 
the service.
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Bacterial testing 
Three of the five laboratories could provide the data on the 
percentage of positive bacterial samples since the database for 
the other laboratories was not set up to flag positive cases. The 
number of positive samples from these three laboratories was 
compared to the number which was actually notified to the DSU 
system8 (Table 1).  
Salmonella formed part of the routine screen for stool 
sample analysis.  
Shigella was part of the routine screen at four of the 
laboratories with a total of 2,171 samples being tested in four 
laboratories in 2005. 
Campylobacter was another routine screen. No direct 
non-culture methods are used by any of the laboratories for 
identification of Campylobacter.
Four of the laboratories test for E. coli 0157 and Shiga toxin 
producing E. coli (STEC).  This was carried out routinely in two 
laboratories but only when a physician specifically requested 
such a test in another two laboratories.  When testing for E. coli 
0157 the laboratories used different media/methods including: 
MacConkey agar 9, chromagar 0157, immunomagnetic beads and 
Sorbitol-MacConkey agar.  When sorbitol colonies are detected, 
different methods were used including a test to detect the 0157 
antigen, a test to detect the H7 antigen, a biochemical test to 
identify the organism as E. coli, sending the isolate to a reference 
laboratory, performing verotoxin detection or a combination of 
some of these methods.   Non-culture methods to screen for  E. coli 
or STEC are not used by any of the laboratories. 
None of the local laboratories processed faecal samples 
for Vibrio or Yersinia.  One of these laboratories stated that 
they never had any requests and another would send samples 
abroad if requested. There was no Polymerase chain reaction 
(PCR)-based testing facility for bacterial pathogens in any of 
the laboratories.
Parasitic testing 
During 2005, there were 1,444 faecal specimens submitted 
to four laboratories for enteric parasite screening. Samples 
were routinely (>80% of times) received as faeces in a container 
without transport media.   All samples were analysed on site. 
Different procedures were used for testing for ova, cysts and 
parasites which included wet mounts before concentration or 
sedimentation, formalin-ethyl acetate concentration, modified 
ZN stain for Cryptospridium parvum, Weber modified trichrome 
stain for Microsporidia species, Lugol’s iodine staining, buffered 
methylene blue and Lugol’s iodine, Wheatley trichrome stain or 
a combination.  Only one of the laboratories carried out testing 
for Cryptosporidium, Cyclospora and Microsporidia. Thirty 
eight out of 114 samples tested for Cryptosporidium in 2005 
resulted in a positive test; none were positive for Cyclospora 
out of 114 tested and none were positive for Microsporidia 
out of 2 tested.  In this laboratory, Cryptosporidium and 
Cyclospora testing was carried out on all liquid faecal specimens 
submitted for ova and parasites using an acid-fast stain, whilst 
Microsporidia testing was performed only when requested using 
chromotype stain.
Viral testing 
Viral testing for enteric pathogens was only performed in 
two of the laboratories.  Specimens were routinely received 
as faeces in a container without transport media.  One of the 
laboratories sent samples for norovirus and rotavirus typing 
abroad.  The only analysis made was for rotavirus which was 
performed using enzyme immunoassay.  No other viral enteric 
pathogens were tested for.
Notification	practices
All laboratories replied to this section of the questionnaire. 
A separate response was obtained from the virology section 
of the main state hospital leading to a total of six responses. 
All of these laboratories stated that they notified cases of 
communicable disease which they encountered in their analysis 
knowing that this is a legal obligation.  Regular mail was the 
most common mode of sending notifications although one 
laboratory used fax and two used emails.  The lag time from 
diagnosis to transmission of report varied from the same day 
up to one week or more.  
Feedback was welcomed by all the laboratories, with the 
method most preferred by half of them being via a website; 
others preferred the annual report and the newsletter.  Quarterly 
feedback was the most accepted frequency for feedback 
using internet or email as a medium for communication. 
Topics preferred were mainly information on outbreaks and 
epidemics as well as detection of imported diseases.  Some 
welcomed information on trends in communicable diseases 
and vaccination activities. 
Table 1: Number of positive samples for bacterial pathogens from those analysed 
 in three laboratories compared to total notified
Pathogen Number of 
samples analysed
Number of 
positive samples
% positive Number	of	notified	cases	
from laboratories
Salmonella 2064 89 4.3 99
Campylobacter 2140 75 3.5 96
E. coli 2967 24 0.8 23
Shigella 2064 0 0 0
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All laboratories kept electronic records of the results of their 
investigations.  However there was no flagging system whereby 
positive results could be electronically selected and there was no 
means for electronic linkage to the DSU database.
Discussion
Infectious intestinal disease is often self-limiting and is 
usually treated without a definitive diagnosis or confirmation 
of the aetiological agent.  The focus group study on physicians13 
has identified this and we know that many of the cases occurring 
never come up for testing.  However, from the public health 
point of view, information on the aetiological organism is very 
important for monitoring trends; as an early warning for the 
identification of outbreaks; for introducing control measures 
and for informing on policies.  Whilst encouraging physicians 
to request stool samples, it is essential to assess the factors 
which could impact on the finding of the aetiological agent in 
local laboratories.  
The response rate for the study was 100%.  Being a small 
country with only a few laboratories it was essential to have 
all replies to the survey questionnaire so as to have an overall 
high response rate which would be representative.  On the 
other hand it must be acknowledged that this may have been 
affected by the fact that the survey originated from a state health 
department.  This may also have biased some of the results which 
laboratories might have been reluctant to admit, for example, to 
not notifying, despite the anonymity of the survey. 
This study has shown that the main bulk of stools being 
submitted are sent to the microbiology laboratory of the main 
state hospital.  The majority of persons who require hospital 
admission are admitted to this main state hospital which has 
a free of charge service for Maltese residents.  Some prefer to 
go to a private hospital. The main state hospital laboratory also 
receives samples from the hospital’s outpatients’ department 
and from general practitioners both those working for the state 
and those in private practice.  
The majority of samples were received without a transport 
medium.  This is known to decrease pathogen viability especially 
if the sample is not tested immediately.14  Hence, it would 
decrease the yield rate of pathogen isolation.  Notification 
from the laboratory was usually carried out within the day of 
results issued but some reported more than a week later.  This 
would also jeopardise the public health investigations which are 
required to be taken, particularly for outbreaks. 
Although there was some consistency in testing for 
Salmonella and Campylobacter, there were variations in routing 
testing for other pathogens, especially for E. coli 0157/STEC. 
Testing for this pathogen was not routine as it is for Salmonella 
and Campylobacter, with the consequence that unless a 
physician suspects and requests this pathogen, it is not tested 
for.  This would lead to an underestimation of the true rates.
No tests are performed for Vibrio or Yersinia in local 
laboratories.  PCR testing for bacteria is not available either 
leading to a decrease the range of pathogen identification from 
stools. PCR has considerable advantages in terms of sensitivity, 
specificity, speed, range of targets and standardisation over 
conventional methodologies.
Similarly for parasites, different methods are used for 
analysis and many laboratories do not routinely test stool 
specimens for parasites.  As a result, parasitic diseases are likely 
to be under diagnosed and under reported.  This has also been 
reported from other studies carried out in other countries.15,16  
The only enteric viral pathogen tested for in Maltese 
laboratories is rotavirus and only 2 laboratories conduct this. 
A study on IID in the community in Malta13 has shown that 
a high proportion of cases in the community are caused by 
norovirus, and since this study has confirmed that this test is 
not performed routinely in Malta, it may explain why a large 
number of cases which are notified to the surveillance system 
remain unspecified (aetiological agent not identified).  This 
great degree of viral under reporting has also been shown in 
UK figures, where only one in every 35 cases of rotavirus were 
reported17, and in a Canadian laboratory study where only 14,051 
samples were tested for viruses compared to 460,000 samples 
for bacteria.16
Another very important factor in the surveillance pyramid 
is that positive cases are notified.  This study has revealed 
important aspects of notification by laboratories.  All of the 
laboratories have confirmed that they do notify -  but do they 
notify all cases?  If the information of the percentage of positive 
cases was available from the laboratories, this could have been 
assessed.
Postal mail has been the traditional mode of sending 
notification forms.  However, today with modern technology, 
different systems can be applied.  Some are already using e-mail, 
although electronic security issues arise in this respect.  For the 
main state hospital laboratory, the notifications are collected by 
hand on a daily basis, and in urgent cases the surveillance unit 
is informed by telephone.  Automated systems for electronic 
data transfer would reduce the burden of data entry.18-20 All 
laboratories in Malta have electronic records.  An assessment 
of the cost-effectiveness of implementing such a system, 
including the costs of computer software and secure systems is 
required.  Such an automated data transfer system would assist 
in generating hypothesis, monitoring trends, and detecting 
clusters or outbreaks.21  A successful electronic reporting system 
needs public health coordination, standardised case definitions, 
careful planning and system support.  With the introduction of 
electronic reporting in Hawaii, the total number of laboratory 
based reports doubled.22  It has been known to enhance the 
quality of surveillance systems by simplifying reporting, 
improving completeness and increasing timeliness.23-25
Feedback has been seen as one of the most effective ways 
of improving notification.13,26 The website was the most 
recommended route for this among laboratories as found in 
GPs, now that internet is widely available.  The frequency of 
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feedback is realistic with quarterly feedback on variable subjects 
more related to the detection of cases and outbreaks rather than 
to prevention measures.  
This study is subject to several limitations.  Although the 
response rate was 100%, the number of laboratories involved 
is small.  Yet, the study was able to reveal that the frequency of 
some pathogens may be underestimated because the laboratories 
do not do routine testing for them and physicians often do not 
request specific tests which are required. This contributes to 
another key area in the national surveillance system where cases 
are lost.  Interventions to improve notification at laboratory 
level would assist in decreasing the lost cases which have been 
laboratory confirmed.  Notification by laboratories does not 
replace the clinician’s responsibility to notify cases especially 
where foodborne illness is suspected.
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